Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray
- 31 March 1997
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 67 (3) , 469-473
- https://doi.org/10.1016/s0015-0282(97)80071-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Radioimmunoassay of Ganirelix in Plasma or SerumJournal of Immunoassay, 1993
- Potent gonadotropin releasing hormone antagonists with low histamine-releasing activityJournal of Medicinal Chemistry, 1992
- Inhibition of Follicular Development by a Potent Antagonistic Analog of Gonadotropin-Releasing Hormone (Detirelix)*Journal of Clinical Endocrinology & Metabolism, 1991
- Variable Ovarian Response to Gonadotropin-Releasing Hormone Antagonist-Induced Gonadotropin Deprivation during Different Phases of the Menstrual Cycle*Journal of Clinical Endocrinology & Metabolism, 1991
- Evidence of Differential Control of FSH and LH Secretion by Gonadotropin-Releasing Hormone (GnRH) from the Use of a GnRH Antagonist*Journal of Clinical Endocrinology & Metabolism, 1988
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗Journal of Clinical Endocrinology & Metabolism, 1986
- Gonadotropin releasing hormone activation is mediated by dimerization of occupied receptorsBiochemical and Biophysical Research Communications, 1985
- Reproductive/endocrine and anaphylactoid properties of an LHRH-antagonist, ORF 18260 [Ac-DNAL1(2),4FDPhe2,D-Trp3,D-Arg6]-GnRHLife Sciences, 1985
- Luteinizing hormone release from dissociated pituitary cells by dimerization of occupied LHRH receptorsNature, 1982